Noninflammatory degenerative joint disease including osteoarthritis, . traumatic arthritis, or avascular necrosis.
Inflammatory degenerative joint disease including rheumatoid arthritis. ●
Correction of functional deformity such as varus, valgus, or flexion . deformities.
Revision procedures where other treatments or devices have failed. .
. Treatment of fractures that are unmanageable using other techniques.

The device is intended for single use only.

The Active Knee® System is contraindicated for the following conditions:

Acute or chronic infections, either local or systemic: .
Severe muscular, nervous or vascular disease endangering the leg; .
Defective bone structures, which could impede adequate anchoring of the ● implant:
Patients who are younger than 60 years whose joint disease is such that . good results may be achieved by using other reconstructive procedures such as osteotomy and;
. All associated diseases which could endanger the function and success of the implant.

Device Description

The Active Knee System is a modular knee system consisting of a femoral component, a standard meniscal insert, an ultracongruent meniscal insert (tibial insert), a patella, and a tibial baseplate.

AI/ML Overview

The provided document describes a 510(k) premarket notification for the Alaron Surgical Active Knee® System. It focuses on demonstrating substantial equivalence to a predicate device rather than presenting detailed acceptance criteria and a study proving the device meets them in the context of AI/software performance.

Therefore, many of the requested sections about AI/software performance and ground truth cannot be answered from the provided text. The document describes a physical medical device (a knee prosthesis), not a software or AI device.

However, I can extract the relevant information regarding the performance testing and its intention from the document provided, even if it doesn't align with the specific AI-centric questions.

Here's an analysis of the provided text in relation to your request:

1. A table of acceptance criteria and the reported device performance

The document does not explicitly state numerical acceptance criteria in a pass/fail format, nor does it provide specific quantitative results of the "reported device performance." Instead, it states that the device performance was "similar" to contemporary knee designs and met recommendations.

Performance Characteristic	Acceptance Criteria (Implicit)	Reported Device Performance
Range of motion and constraint	Conform to existing standards/recommendations; comparable to predicate.	Tested as recommended by FDA Draft Guidance (April 1993, updated December 1998) for Cemented, Semi-Constrained Total Knee Prosthesis. "Demonstrated similar performance characteristics" compared to "other contemporary knee designs" and was "substantially equivalent" to the Sulzer Orthopedics Natural-Knee II Constrained Knee System (K973412) and "other similar marketed devices."
Surface roughness characteristics	Conform to existing standards/recommendations; comparable to predicate.	Tested as recommended by FDA Draft Guidance. "Demonstrated similar performance characteristics" compared to "other contemporary knee designs" and was "substantially equivalent" to the Sulzer Orthopedics Natural-Knee II Constrained Knee System (K973412) and "other similar marketed devices."
Contact areas and surface stress	Conform to existing standards/recommendations; comparable to predicate.	Tested as recommended by FDA Draft Guidance. "Demonstrated similar performance characteristics" compared to "other contemporary knee designs" and was "substantially equivalent" to the Sulzer Orthopedics Natural-Knee II Constrained Knee System (K973412) and "other similar marketed devices."
Resistance to lateral subluxation	Conform to existing standards/recommendations; comparable to predicate.	Tested as recommended by FDA Draft Guidance. "Demonstrated similar performance characteristics" compared to "other contemporary knee designs" and was "substantially equivalent" to the Sulzer Orthopedics Natural-Knee II Constrained Knee System (K973412) and "other similar marketed devices."
Fatigue strength	Conform to existing standards/recommendations; comparable to predicate.	Tested as recommended by FDA Draft Guidance. "Demonstrated similar performance characteristics" compared to "other contemporary knee designs" and was "substantially equivalent" to the Sulzer Orthopedics Natural-Knee II Constrained Knee System (K973412) and "other similar marketed devices."

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document does not specify a "test set" in the context of data. It refers to "Performance testing" conducted on the physical device components (femoral, tibial baseplate, standard meniscal insert, ultracongruent meniscal insert, and patella prostheses). The sample size for these physical tests (e.g., number of components tested for fatigue) is not provided. The data provenance is not applicable as this is a physical device testing, not a data-driven AI study.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This is not applicable. "Ground truth" for a physical knee prosthesis would refer to the physical and mechanical properties of the device, established through engineering testing and material science, not through expert human interpretation of data for AI.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This is not applicable, as there is no "test set" or human adjudication involved in the performance testing described.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This is not applicable. The device is a physical knee implant, not an AI software designed to assist human readers.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This is not applicable. The device is a physical knee implant, not an algorithm.

7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

For the performance testing of the physical device, the "ground truth" would be established by engineering standards, material specifications (ASTM F75, ASTM F648), and mechanical testing protocols recommended by the FDA Guidance (April 1993, updated December 1998). The conclusion of "substantially equivalent" indicates that its performance matched the established benchmarks from the predicate device and other contemporary designs.

8. The sample size for the training set

This is not applicable, as there is no "training set" for a physical device like this.

9. How the ground truth for the training set was established

This is not applicable, as there is no "training set" for a physical device like this.

Summary of the Document's Core Information Regarding Performance:

The document describes the performance testing of the Alaron Surgical Active Knee® System, a physical knee prosthesis. The testing was conducted according to FDA Draft Guidance for Cemented, Semi-Constrained Total Knee Prosthesis (April 1993, updated December 1998). The tests covered:

Range of motion and constraint (stability characteristics)
Surface roughness characteristics
Contact areas and surface stress
Resistance to lateral subluxation
Fatigue strength

The conclusion of the testing was that the Active Knee® System "demonstrated similar performance characteristics" when compared to other contemporary knee designs and was "substantially equivalent" to the Sulzer Orthopedics Natural-Knee II Constrained Knee System (K973412) and other similar marketed devices. This "substantial equivalence" is the primary acceptance criterion for a 510(k) submission, and the performance testing described served as the study to demonstrate this.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo for DJ Ortho. The logo consists of the letters "dj" in a cursive font, followed by the word "ortho" in a sans-serif font. The word "ortho" is set against a black background. There is a trademark symbol in the upper right corner of the black background.

K021740

page 1 of 4

510(k) Summary

Submitted by:	dj Orthopedics, LLC2985 Scott StreetVista, CA 92083-8339 U.S.A.Tel: (760) 734-3122Fax: (760) 734-5544
Date:	May 24, 2002
Submitted by:	Nora C.R. York, Regulatory Affairs Manager
Trade Name:	Alaron Surgical Active Knee® System
Classification Name:	Prosthesis, knee joint, patellofemorotibial.polymer/metal /polymer semi-constrainedcemented prosthesis - 888.3560 (87JWH)
Common/Usual Name:	Knee Prosthesis, Partially Constrained

Substantially Equivalence:

The Active Knee® System is substantially equivalent to the Sulzer Orthopedics Natural-Knee II Constrained Knee System, K973412.

Product Description:

Device System

The Active Knee System is a modular knee system consisting of a femoral component, a standard meniscal insert, an ultracongruent meniscal insert (tibial insert), a patella, and a tibial baseplate.

Femoral Component

The femoral component is an anatomic, asymmetrically designed prosthesis manufactured from cast cobalt chromium/molybdenum (ASTM F75). The condylar prosthesis was designed for optimal weight transmission and flexion as well as giving maximum contact area to reduce material stress on the meniscal The design incorporates a trochlear groove, which conforms to the insert. geometry of the patellar prosthesis and allows for sliding articulation. From the medial/lateral view, the condylar geometry has a radial inward and upward sweep in the coronal plane, which assists in maximizing the contact area.

{1}------------------------------------------------

021740
page 2 of #

sweep in the coronal plane, which assists in maximizing the contact area. Anterior and posterior cuts are not parallel. There is a two (2) degree flaring, encouraging loading distally.

The interior box of the cemented femur is designed with a recess into the distal end of the prosthesis to enhance polvmethylmethacrvlate (PMMA) fixation.

The femoral components are available in seven (7) sizes: small medium. regular-narrow, regular, large-narrow and extra large in both a right and left implant.

Tibial Baseplates

The tibial baseplates are symmetrical . The baseplates are manufactured from grit-blasted cobalt chromium/molybdenum (ASTM F75). The baseplates are available in ten (10) sizes, small, medium, regular, large and extra-large, in both a narrow and a wide version.

The inferior surface of the tibial baseplate is grit blasted to further enhance cement fixation. A central keel on the inferior surface allows for insertion onto the tibia.

Standard Meniscal Insert (Tibial Insert)

The standard meniscal insert is symmetrical and available in seven (7) sizes, small, medium, regular narrow, large, large, large narrow, extra-large, of five (5) different thickness of each (6mm, 7.5mm, 11.5mm, 13.5mm). The minimum polyethylene thickness is 6mm. The meniscal insert is designed with a clip-on mechanism on the underside to secure a firm seat in the capture feature of the tibial tray.

The standard meniscal insert is a semi-constrained condylar design and is manufactured from Ultra-High Molecular Weight Polyethylene (UHMWPe, ASTM F-468). Additional posterior stability can be provided utilizing the ultracongruent meniscal insert, which is designed with an anterior lip.

Patella

The patella has a dome shape with the reverse curvature of the femoral condyles. The patello-femoral geometry consists of a deep trochlear groove for complete articular conformity. The patella is designed with three (3) small stems for fixation with PMMA cement. The patella is available in five sizes, small, medium, reqular, large, and extra-large.

{2}------------------------------------------------

Intended Use/Indications for Use:

Q21740
page 3 of 4

The Active Knee® System is indicated to be used only with bone cement in patients suffering from the following conditions:

Noninflammatory degenerative joint disease including osteoarthritis, . traumatic arthritis, or avascular necrosis.
Inflammatory degenerative joint disease including rheumatoid arthritis. ●
Correction of functional deformity such as varus, valgus, or flexion . deformities.
Revision procedures where other treatments or devices have failed. .
. Treatment of fractures that are unmanageable using other techniques.

The device is intended for single use only.

The Active Knee® System is contraindicated for the following conditions:

Acute or chronic infections, either local or systemic: .
Severe muscular, nervous or vascular disease endangering the leg; .
Defective bone structures, which could impede adequate anchoring of the ● implant:
Patients who are younger than 60 years whose joint disease is such that . good results may be achieved by using other reconstructive procedures such as osteotomy and;
. All associated diseases which could endanger the function and success of the implant.

Performance Testing:

Performance testing was conducted for the Active Knee System as recommended by the FDA Draft Guidance for the Preparation of Premarket Notifications 510(k)s for Cemented, Semi-Constrained Total Knee Prosthesis dated April 1993 and updated on December 8, 1998. The testing was conducted for the femoral, tibial baseplate, standard meniscal insert, ultracongruent meniscal insert (posterior stabilizer) and the patella prostheses. Testing consisted of range of motion and constraint (stability characteristics), surface roughness characteristics, contact areas and surface stress, resistance to lateral subluxation and fatigue strength.

When compared to other contemporary knee designs, the Active Knee System demonstrated similar performance characteristics.

{3}------------------------------------------------

Bio-compatibility:

K 021740
page 4 of 4

The Active Knee® System is made of materials for surgical implant applications. The materials used for the implants are ASTM F75 Specifications for Cast Cobalt-Chromium-Molybdenum Alloy for Surgical Implant Applications and ASTM F648 Specifications for Ultra-High Molecular Weight Polyethylene Powder and Fabricated Form for Surgical Implants.

Sterilization:

Metal implants are sterilized with 25 to 42 kGy (2.5 to 4.2 Mrad) gamma . radiation per ISO 11137.
Polyethylene implants are sterilized with Ethylene Oxide per EN 550. .

Conclusion:

The performance testing demonstrated that the Active Knee® System is substantially equivalent to the Sulzer Orthopedics Natural-Knee II Constrained Knee System, K973412 and other similar marketed devices.

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" are arranged in a circle around the eagle. The eagle is black, and the text is also black. The logo is simple and recognizable.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 23 2002

Ms. Nora C. R. York Regulatory Affairs Manager dj Orthopedics, LLC 2985 Scott Street Vista, California 92083-8339

Re: K021740

Trade/Device Name: Alaron Surgical Active Knee System Regulation Number: 21 CFR 888.3560 Regulation Name: Knee joint patellofemorotibial polymer semi-constrained cemented prosthesis Regulatory Class: II Product Code: JWH Dated: August 30, 2002

Received: September 3, 2002

Dear Ms. York:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{5}------------------------------------------------

Page 2 - Ms. Nora C. R. York

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely vours.

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{6}------------------------------------------------

INDICATIONS FOR USE

221740

510(k) Number (if known):

Device Name: Alaron Surgical Active Knee® System

Indications For Use:

The Alaron Surgical Active Knee® System is semi-constrained and is intended to be used only with bone cement in patients suffering from the following conditions:

Non-inflammatory degenerative joint disease including osteoarthritis, traumatic . arthritis, or avascular necrosis.
Inflammatory degenerative joint disease including rheumatoid arthritis. .
Correction of functional deformity such as varus, valgus, or flexion deformities. .
Revision procedures where other treatments or devices have failed. .
Treatment of fractures that are unmanageable using other techniques. .

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device

ice of Device Evaluation (ODE)

Mark N Milburn

Division Sign-Off

Division of General, Restorative
and Neurological Devices

j(k) Number

(Optional Format (3-10-98)

Regulation Number and Section

§ 888.3560 Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis.

(a)
Identification. A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.